Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial.

Details

Language :

English

ISSN :

21522650

Volume :

13

Issue :

2

Database :

Complementary Index

Journal :

Clinical Lymphoma, Myeloma & Leukemia

Publication Type :

Academic Journal

Accession number :

92000958

Full Text :

https://doi.org/10.1016/j.clml.2012.11.002